HYDROXYUREA THERAPY FOR SICKLE CELL ANEMIA

羟基脲治疗镰状细胞贫血症

• 批准号: 3765151
• 负责人: SAMUEL CHARACHE
• 金额: --
• 依托单位: JOHNS HOPKINS UNIVERSITY
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3765151
• 关键词: blood disorder chemotherapy; human subject; human therapy evaluation; hydroxyurea; longitudinal human study; sickle cell anemia

Several patients, treated according to a protocol which was completed five years ago, continue to take hydroxyurea and are followed for evidence of chronic or slowly-developing toxicity.

几名患者根据完成的方案接受治疗 五年前，继续服用羟基脲， 慢性或缓慢发展毒性的证据。